Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Search Results

Title:
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Protocol Number:
J1227
Phase:
Phase II
Physician:
Margaret Showel
Purpose:
This research is being done to find out if an evaluation of leukemia stem cells can guide further treatment for acute myelogenous leukemia (AML) and improve patient outcomes. Specifically, to determine IF a new experimental lab test to look for leukemia stem cells, can predict whether patients with AML will benefit from stem cell transplant (SCT) given earlier in treatment. This research study proposes to test patients for evidence of leukemia stem cells at the time of first remission and base further therapy on whether or not leukemia stem cells are present.
Eligibility:
Age 18 years to 75 yearsNew diagnosis of AML, other than APL or poor-risk AMLthat has been treated with induction therapy in the last four weeks
Treatment:
Patients without detectable leukemia stem cells by flow cytometry, will be assigned to standard cytarabine-based chemotherapy as per institutional standards. Patients with detectable leukemia stem cells by flow cytometry will be randomized to either standard cytarabine-based consolidation therapy or allogeneic stem cell transplant, per institutional standards. Patients will receive the transplant from a related donor who is at least a haploidentical match. The choice of the optimal donor will use institutional priority extant at the time. Patients eligible for myeloablative conditioning will be prioritized to receive it; patients not eligible for myeloablative conditioning will receive non-myeloablative conditioning.
Population:
Adult
Last Update
07/24/2014 04:10 AM
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

Cancer Dictionary

NCI Dictionary of Cancer Terms, a resource with more than 6,000 terms related to cancer and medicine.

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer